Stockscreener 앱 받기
163.75
0.36%
0.58
시간 외 거래:
163.75
전일 마감가:
$163.17
열려 있는:
$167.57
하루 거래량:
706.26K
Relative Volume:
0.89
시가총액:
$9.66B
수익:
$551.35M
순이익/손실:
$-189.33M
주가수익비율:
-49.75
EPS:
-3.2916
순현금흐름:
$-35.09M
1주 성능:
+6.04%
1개월 성능:
-8.79%
6개월 성능:
+45.21%
1년 성능:
+93.81%
1일 변동 폭
$163.01
$168.08
1주일 범위
$151.71
$168.73
52주 변동 폭
$73.16
$191.62
Glaukos Corp Stock (GKOS) Company Profile
명칭
Glaukos Corp
전화
949-367-9600
주소
1 GLAUKOS WAY, ALISO VIEJO, CA
Compare GKOS vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corp
|
163.75 | 9.11B | 551.35M | -189.33M | -35.09M | -3.2916 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Glaukos Corp Stock (GKOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-06 | 개시 | H.C. Wainwright | Buy |
| 2025-10-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | 개시 | Goldman | Buy |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-05-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-12-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-11-28 | 개시 | Truist | Buy |
| 2023-11-08 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-04 | 개시 | Needham | Buy |
| 2022-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2022-02-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-11-03 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
| 2020-12-09 | 개시 | Oppenheimer | Perform |
| 2020-11-17 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-06-15 | 개시 | Jefferies | Hold |
| 2020-03-05 | 개시 | Citigroup | Sell |
| 2020-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-01-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-12-12 | 다운그레이드 | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | 개시 | BTIG Research | Neutral |
| 2018-08-30 | 개시 | Berenberg | Hold |
| 2018-08-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-03 | 재확인 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-04-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-01 | 재확인 | Cantor Fitzgerald | Buy |
| 2017-03-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2016-10-27 | 개시 | Wells Fargo | Outperform |
모두보기
Glaukos Corp 주식(GKOS)의 최신 뉴스
Glaukos Corporation (GKOS) Stock Forecasts - Yahoo Finance
A Look at Glaukos Corp (GKOS) After 3.6% Gain -- GF Value $153.8 - GuruFocus
Form 4 Glaukos Corp For: 28 September By Investing.com - Investing.com Nigeria
Glaukos chief development officer sells $249k in stock By Investing.com - Investing.com Nigeria
Glaukos (GKOS) officer sells shares under a preset plan at weighted-average prices from $151.70 to $154.88 - Stock Titan
Glaukos options activity points to bullish call spread targeting $180 - Investing.com
Form 144 GLAUKOS Corp For: 26 September By Investing.com - Investing.com Nigeria
A Glaukos (NYSE: GKOS) officer proposes selling 1,615 shares on September 25. - Stock Titan
Presbyopia Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | AbbVie, Orasis Pharma, Eyenovia, Glaukos Corp., Ocuphire Pharma, Novartis - Barchart.com
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now - Yahoo Finance
Glaukos Partners with NBA Champion Stephen Curry to Launch “Could - The National Law Review
Zacks Investment Research - גלובס
A Look at Glaukos Corp (GKOS) After 4.0% Decline -- GF Value $15 - GuruFocus
Jefferies Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $210 - moomoo.com
$1000 Invested In Glaukos 10 Years Ago Would Be Worth This Much Today - Benzinga
Glaukos Partners with NBA Champion Stephen Curry to Launch "Could it be KC?" Campaign to Raise Awareness of Keratoconus - Yahoo Finance
Glaukos (GKOS), Why Is It Back In The Spotlight? - Yahoo Finance
Glaukos Corporation (GKOS) Options ChainYahoo Finance - Yahoo! Finance Canada
GKOS Maintained by Jefferies -- Price Target Raised to $210 - GuruFocus
Glaukos stock gains institutional support as Bank of America builds position - AD HOC NEWS
Glaukos chief development officer Tomas Navratil sells $243k in shares - Investing.com India
Glaukos Corp (GKOS) Stock Down 4.8% but Still Overvalued -- GF S - GuruFocus
Glaukos (NYSE: GKOS) officer lines up new stock sale after $2.48M August trade - Stock Titan
Glaukos Corp (GKOS) Key Financial Ratios – Valuation, Profitability & More - Value Research
Cyclo3pss Corporation (CYPS) Peer Comparison – Compare with Others - Value Research
Glaukos Corp (GKOS) Shares Fall 5.2% -- What GF Score of 77 Tells Investors - GuruFocus
Why Glaukos Shares Are Trading Lower Today - Quiver Quantitative
If You Invested $1000 In Glaukos Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Glaukos at Wells Fargo conference: launch ramps, reimbursement risks - Investing.com
Glaukos at Wells Fargo conference: launch ramps, reimbursement risks By Investing.com - Investing.com Canada
Is Glaukos Corp (GKOS) Overvalued After 4.3% Rally? GF Value Say - GuruFocus
Glaukos Corp (NYSE: GKOS) Share Price, GKOS Stock News, GKOS Share Price & Updates - Kalkine
ZimVie Inc. When-Issued (ZIMVV) Peer Comparison – Compare with Others - Value Research
Enterprise value to EBITDA forward of Glaukos Corp – LSX:A14VCK - TradingView
Precipio Inc. (PRPO) Peer Comparison – Compare with Others - Value Research
Mesa Laboratories Inc. (MLAB) Peer Comparison – Compare with Others - Value Research
Bruker Corporation (BRKR) Peer Comparison – Compare with Others - valueresearchonline.com
Haemonetics Corporation (HAE) Peer Comparison – Compare with Others - Value Research
Repligen Corporation (RGEN) Peer Comparison – Compare with Others - valueresearchonline.com
Quidel Corporation (QDEL) Peer Comparison – Compare with Others - Value Research
Heska Corporation (HSKA) Peer Comparison – Compare with Others - Value Research
UFP Technologies Inc. (UFPT) Peer Comparison – Compare with Others - Value Research
Innovative Eyewear Inc (LUCYW) Peer Comparison – Compare with Others - Value Research
Natus Medical Incorporated (NTUS) Peer Comparison – Compare with Others - Value Research
Repro Med Systems Inc. (KRMD) Peer Comparison – Compare with Others - Value Research
TransMedics Group Inc. (TMDX) Peer Comparison – Compare with Others - Value Research
Allied Healthcare Products Inc. (AHPI) Peer Comparison – Compare with Others - Value Research
Codex DNA Inc (DNAY) Peer Comparison – Compare with Others - Value Research
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
InspireMD Inc. (NSPR) Peer Comparison – Compare with Others - Value Research
AtriCure Inc. (ATRC) Peer Comparison – Compare with Others - valueresearchonline.com
Glaukos Corp (GKOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.26%
0.38%
자본화:
|
볼륨(24시간):